Cargando…
Cost-effectiveness of atenolol compared to propranolol as first-line treatment of infantile haemangioma: A pilot study
Propranolol is the first-line agent for the treatment of infantile haemangioma (IH). Due to its non-selective beta blockade respiratory adverse events are commonplace. Atenolol is a selective beta-1 antagonist and is a second line for patients with a significant respiratory history or those intolera...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240956/ https://www.ncbi.nlm.nih.gov/pubmed/35784377 http://dx.doi.org/10.1016/j.jpra.2022.05.010 |